.png)
Some of the most impactful healthcare technologies, diagnostics, digital health tools, medical devices, and care solutions begin with observations made at the point of care.
University Health Network (UHN) researchers and clinicians have created internationally adopted tools that help healthcare providers assess disease severity, predict risk, measure patient outcomes, and support clinical decision-making and improve patient care.
Many of these tools are protected by copyright and may require permission or a licence for certain uses, including industry-sponsored research, commercial applications, software integration, or redistribution.
Researchers interested in developing, protecting, or disseminating a new assessment tool are encouraged to contact the UHN Commercialization Office early in the development process.
Primary Author: Dr. Frances Chung
Purpose: Screening tool for sleep apnea risk.
Primary Indication: Obstructive Sleep Apnea (OSA)
Other indications: metabolic disease, sleep disorders, cardiovascular disease.
Tool Type: Screening tool/questionnaire .
Website: http://www.stopbang.ca
Primary publication: Chung F, Abdullah HR, Liao P. STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea. Chest. 2016 Mar;149(3):631-8. doi: 10.1378/chest.15-0903. Epub 2016 Jan 12. PMID: 26378880.
Available translations/regional adaptations: English (US, Canada, UK, South Africa), Spanish (Spain, Mexico, US, Argentina), French (France, Canada), Afrikaans, Bulgarian, Chinese, Czech, Dutch, Finnish, German (Germany, Austria), Hebrew, Hungarian, Icelandic, Italian, Korean, Malay, Polish, Portugese, Romanian, Serbian, Swedish, Taiwanese, Thai, Turkish, Urdu
Available Formats: Paper, Electronic (ePRO), Research use, Clinical use
* If you are using an Express License for STOP BANG, a UHN representative will review all submitted requests to ensure the fields are completed correctly. If approved, a completed express license agreement will be sent via email for signature to the signatory designated above.
Primary Author: Dr. Carolina Barnett-Tapia
Purpose: A patient-centred measure to assess disease severity
Primary Indication: Myasthenia Gravis
Other indications: No
Tool Type: Clinical Outcomes Assessment (COA)
Website: http://www.stopbang.ca
Primary publication: Barnett C, Bril V, Kapral M, Kulkarni A, Davis AM. Development and validation of the Myasthenia Gravis Impairment Index. Neurology. 2016 Aug 30;87(9):879-86. doi: 10.1212/WNL.0000000000002971. Epub 2016 Jul 8. PMID: 27402891; PMCID: PMC5035154.
Available translations/regional adaptations: Australia (English), Austria (German), Belgium (French, Dutch), Canada (English, French), China (Chinese), Cyprus (Greek), Czech Republic (Czech), Denmark (Danish), Georgia (Georgian), Germany (German), Great Britain (English), Greece (Greek), France (French), Finland (Finnish), Hungary (Hungarian), Italy (Italian), Japan (Japanese), Netherlands (Dutch), Norway (Norwegian), Poland (Polish), Portugal (Portuguese), Romania (Romanian), Saudi Arabia (Arabic), Serbia (Serbian (Latin)), South Korea (Korean), Spain (Spanish, Catalan), Sweden (Swedish), United Arab Emirates (Arabic), United States (English, Spanish)
Primary Author: Dr. Sukhvinder Kalsi-Ryan
Purpose: Clinical impairment measure specific to upper limb use post-tetraplegia
Primary Indication: Upper limb post traumatic tetraplegia
Tool Type: Clinical Outcomes Assessment (COA)
Website: https://www.grassptest.com
Primary publication: Development of the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP): reviewing measurement specific to the upper limb in tetraplegia. Curt A, Fehlings MG, Kalsi-Ryan S, Verrier MC. J Neurosurg Spine. 2012 Sep;17(1 Suppl):65-76. PMID: 22985372. – C
Available translations/regional adaptations: English, French (Canadian), German, Italian, Czech, Spanish